Kim-Hafken Tina
Consigliere Generale presso RAIN ONCOLOGY INC.
Profilo
Kim-Hafken Tina is currently working as Vice President-Regulatory Affairs at Rain Oncology, Inc. Previously, she worked as Senior Director-Regulatory Affairs at Seagen Inc. She completed her undergraduate degree from The Johns Hopkins University and the University of Kansas.
Posizioni attive di Kim-Hafken Tina
Società | Posizione | Inizio |
---|---|---|
RAIN ONCOLOGY INC. | Consigliere Generale | - |
Precedenti posizioni note di Kim-Hafken Tina
Società | Posizione | Fine |
---|---|---|
SEAGEN INC. | Consigliere Generale | - |
Formazione di Kim-Hafken Tina
The Johns Hopkins University | Undergraduate Degree |
University of Kansas | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Kim-Hafken Tina